A Dose Escalation Study of NanO2 in Patients With Mild Respiratory Distress

NCT06658535 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

Mild Respiratory Distress

Interventions

DRUG: dodecafluoropentane (0.025 mL/kg)
DRUG: dodecafluoropentane (0.032 mL/kg)
DRUG: dodecafluoropentane (0.050 mL/kg)

Sponsor

NuvOx LLC